PTEN and neoplasm: This classification system identifies a subtype of highly aggressive tumours with poor outcomes, characterized by gene expression signatures for embryonic and induced pluripotent stem cells (ESC, iPSC), and for loss of function of the tumour suppressors PTEN and p53.